Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5276366
Max Phase: Preclinical
Molecular Formula: C52H58N8O9S
Molecular Weight: 971.15
Associated Items:
ID: ALA5276366
Max Phase: Preclinical
Molecular Formula: C52H58N8O9S
Molecular Weight: 971.15
Associated Items:
Canonical SMILES: Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCC(=O)NCCCC(=O)Nc2cccc(Cc3c(C)c4ccc(Oc5ncccn5)cc4oc3=O)c2)C(C)(C)C)cc1
Standard InChI: InChI=1S/C52H58N8O9S/c1-30-39-18-17-38(68-51-54-22-9-23-55-51)27-42(39)69-50(67)40(30)25-33-10-7-11-36(24-33)58-44(63)12-8-21-53-43(62)19-20-45(64)59-47(52(4,5)6)49(66)60-28-37(61)26-41(60)48(65)57-31(2)34-13-15-35(16-14-34)46-32(3)56-29-70-46/h7,9-11,13-18,22-24,27,29,31,37,41,47,61H,8,12,19-21,25-26,28H2,1-6H3,(H,53,62)(H,57,65)(H,58,63)(H,59,64)/t31-,37+,41-,47+/m0/s1
Standard InChI Key: XFWUEFJLWRQESX-GANDGMNLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 971.15 | Molecular Weight (Monoisotopic): 970.4047 | AlogP: 6.69 | #Rotatable Bonds: 18 |
Polar Surface Area: 235.05 | Molecular Species: NEUTRAL | HBA: 13 | HBD: 5 |
#RO5 Violations: 3 | HBA (Lipinski): 17 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.47 | CX Basic pKa: 2.65 | CX LogP: 4.10 | CX LogD: 4.10 |
Aromatic Rings: 6 | Heavy Atoms: 70 | QED Weighted: 0.04 | Np Likeness Score: -0.72 |
1. Wang C, Wang H, Zheng C, Li B, Liu Z, Zhang L, Yuan L, Xu P.. (2023) Discovery of Coumarin-Based MEK1/2 PROTAC Effective in Human Cancer Cells., 14 (1.0): [PMID:36655129] [10.1021/acsmedchemlett.2c00446] |
Source(1):